By Steve Hamm
IBM researcher Solomon Assefa likes to operate at the intersections of scientific domains and social institutions. It allows him to envision ways of using cutting-edge technologies to tackle new challenges. In a recent example of how his approach can pay off, he made the connections that resulted in a small team of IBM scientists helping boost a United Nations Children’s Fund social networking project that could improve the lives of millions throughout the continent of Africa. Continue Reading »
By Dr. Courtney DiNardo
A few weeks ago, after I started one of my leukemia patients at MD Anderson Cancer Center on a standard course of chemotherapy, my patient developed a potentially life-threatening complication that sometimes occurs during leukemia treatment. It’s called tumor lysis syndrome. If not treated proactively, it can cause kidney failure, a heart attack and even death. A computing system based on IBM’s Watson technology that we’re currently piloting alerted me to the situation. I took action immediately. He’s okay now.
At an advanced cancer treatment center like MD Anderson, we likely would have spotted my patient’s problem early enough to respond in time without the help of a computer. However, in a community hospital, physicians who don’t see as many leukemia patients or have our expertise might not have noticed in time. The technology will definitely save lives. Continue Reading »
By Richard Ware
I have always been healthy and active, so I was stunned earlier this year when I was diagnosed with myelodysplastic syndrome, a form of leukemia I was referred to a cancer treatment center in Utah where I felt rushed into a treatment that was presented as the only option. I contacted MD Anderson for a second opinion and higher level of competence and a new, cutting-edge treatment option for my condition.
They recommended that I try an experimental chemotherapy treatment regimen that had shown positive outcomes for otherwise healthy middle-aged people like me. I began chemotherapy in September and have already seen positive results. Dr. Courtney DiNardo is my primary physician. Continue Reading »
By Richard Silberman, Writer/Researcher, IBM Communications
For the past four years, Yu Deng has had her head in the cloud – working on nearly 20 cloud computing inventions for which she has filed or received patents. An IBM Master Inventor and researcher in services analytics and knowledge management, Deng is lead or co-inventor on innovations that will make cloud computing easier, more accessible and more affordable.
Deng’s work at IBM’s Thomas J. Watson Research Center, in Yorktown Heights, N.Y., is helping define a new type of cloud service delivery model and propel cloud computing into the future. One of Deng’s key ideas, which is up for patent, would help make catalog management flexible and extensible over the cloud. Continue Reading »
By Michael Barborak
When IBM’s Watson defeated two grand-champions on the TV quiz show, Jeopardy!, the world’s smartest computer was matched up against two really smart humans. The quiz-show win captured peoples’ attention, but, these days, as we identify uses for Watson throughout society, it’s becoming clear that these technologies will be used primarily to augment human intelligence, not compete with people or replace us.
It’s not human versus machine, but human plus machine taking on challenges together and achieving more than either could do on its own. Nowhere is this powerful new one-two punch clearer than in the world of medicine and healthcare. Cognitive machines have the potential to help physicians diagnose diseases and assess the best treatments for individual patients. But, to make the most of this opportunity, machines will have to be designed and trained to interact with doctors in ways that are most natural to them. Continue Reading »
By Dharmendra Modha
Five years ago, a team made up of scientists from IBM, several universities and two US national laboratories embarked on a great quest: to design a computer chip inspired by the function, low-power, and compact size of the human brain. In the face of tremendous technical unknowns, our goal is now within reach.This was no easy journey. As the principal investigator, I had to coordinate the activities of scientists with a wide variety of skills and expertise, both within IBM and at the other organizations that collaborated with us. We had to achieve a series of significant scientific breakthroughs in a virtually uncharted territory under the constraints of a relatively short deadline and limited funds. Continue Reading »
By Laura Haas
One year ago, when I was talking to medical researchers in Texas about potential research collaborations, I experienced one of those great aha! moments that scientists live for. I had mentioned work we were doing in using text analytics on the medical literature to accelerate drug discovery. One of the researchers I was speaking to connected the dots between that project and an element of IBM’s Watson technology—the ability for Watson to generate hypotheses.
He said: Why not combine these technologies to help predict the next promising experiment that could be undertaken in any line of scientific inquiry? Out of that revelation came a deep collaboration between Baylor College of Medicine and IBM to accelerate the discovery of new drugs to treat and cure diseases such as cancer, Alzheimer’s and ALS. Continue Reading »
By Dr. Walter Stewart
Heart failure remains nearly impossible to detect early.
Although doctors look for physical signs and symptoms, which are commonly known as the Framingham criteria, they can occur with illnesses other than heart failure. So, doctors usually diagnose heart failure after a patient is hospitalized, when the disease has progressed to a very serious stage and caused irreversible organ damage.
Sutter Health, IBM and Geisinger Health Systems have earned a $2 million grant from the National Institute of Health (NIH) to improve this diagnosis – to make it faster, more accurate, and more reliable with analytics. As part of this three year project, we will collect data on heart failure symptoms, test multiple approaches for quickly and accurately analyzing the data, and determine how we might structure a potential clinical trial. Continue Reading »
By Ramesh Gopinath
A lot of the development work on IBM’s Watson, the computer that defeated two former grand-champions on the TV quiz show Jeopardy, was done by a small team of scientists and engineers in New York, near IBM Research headquarters. But you may be surprised to learn that some of the essential components of IBM’s first commercial product based on the Watson technology came from IBM Research –India. As director of the India lab, I’m very proud of that achievement. The contributions from scientists in India demonstrate the value of having a global network of research laboratories. Continue Reading »
By Steve Hamm
IBM hosted the Cognitive Systems Colloquium at its famed IBM Research Center in Yorktown Heights, N.Y., on Oct. 2, 2013. The all-day event brought together leaders in science, technology and psychology to discuss the coming era of cognitive computing and to craft a shared agenda among industry, academia and government.
The following is a time-stamped stream of live updates and insights from the event from presenters including, Nobel Prize laureate Daniel Kahneman, A.I pioneer Danny Hillis, Irving Wladawsky-Berger, Visiting Professor, MIT and Imperial College, and others. Continue Reading »